Is Senseonics Holdings, Inc. (SENS) Halal?

NASDAQ Healthcare United States $274M
✗ NOT HALAL
Confidence: 90/100
Senseonics Holdings, Inc. (SENS) is Not Halal under AAOIFI Standard 21. While the debt ratio of 25.1% is acceptable, the cash and interest-bearing securities ratio of 30.6% exceeds the 30% threshold. Senseonics Holdings, Inc. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 25.1%
/ 30%
30.6%
/ 30%
3.3%
/ 30%
20.03%
/ 5%
✗ NOT HALAL
DJIM 25.1%
/ 33%
30.6%
/ 33%
3.3%
/ 33%
20.03%
/ 5%
✗ NOT HALAL
MSCI 60.8%
/ 33%
74.3%
/ 33%
8.0%
/ 33%
20.03%
/ 5%
✗ NOT HALAL
S&P 25.1%
/ 33%
30.6%
/ 33%
3.3%
/ 33%
20.03%
/ 5%
✗ NOT HALAL
FTSE 60.8%
/ 33%
74.3%
/ 33%
8.0%
/ 50%
20.03%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-1.66
P/B Ratio
4.4
EV/EBITDA
-3.3
EV: $221M
Revenue
$35M
Growth: 71.8%
Beta
1.0
Average volatility
Current Ratio
4.8

Profitability

Gross Margin 44.7%
Operating Margin -146.8%
Net Margin -196.0%
Return on Equity (ROE) -168.3%
Return on Assets (ROA) -37.7%

Cash Flow & Balance Sheet

Operating Cash Flow-$59M
Free Cash Flow-$60M
Total Debt$41M
Debt-to-Equity67.8
Current Ratio4.8
Total Assets$126M

Price & Trading

Last Close$6.56
50-Day MA$7.13
200-Day MA$8.06
Avg Volume519K
Beta1.0
52-Week Range
$5.25
$15.74

About Senseonics Holdings, Inc. (SENS)

CEO
Dr. Timothy T. Goodnow Ph.D.
Employees
130
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$274M
Currency
USD

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Senseonics Holdings, Inc. (SENS) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Senseonics Holdings, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Senseonics Holdings, Inc.'s debt ratio?

Senseonics Holdings, Inc.'s debt ratio is 25.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 60.8%.

What are Senseonics Holdings, Inc.'s key financial metrics?

Senseonics Holdings, Inc. has a market capitalization of $274M, and revenue of $35M. The company maintains a gross margin of 44.7% and a net margin of -196.0%. Return on equity stands at -168.3%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.